Long-term survival and tolerance in allogeneic rat small bowel transplant recipients treated with cyclosporine
Diflo, T.; Maki, T.; Monaco, A.P.
Transplantation Proceedings 21(1 Pt 3): 2885-2886
1989
ISSN/ISBN: 0041-1345 PMID: 2650392 Document Number: 345713
Document emailed within 1 workday
Related Documents
Radovancevic, B.; Birovljev, S.; Frazier, O.H.; Duncan, J.M.; Bennink, W.; Sweeney, M.S.; McAllister, H.A.; Burnett, C.M.; Vega, J.D.; Lonquist, J.L. 1990: Long-term follow-up of cyclosporine-treated cardiac transplant recipients Transplantation Proceedings 22(3 Suppl 1): 21-24Opelz, G.; Schwarz, V.; Engelmann, A.; Back, D.; Wilk, M.; Keppel, E. 1991: Long-term impact of HLA matching on kidney graft survival in cyclosporine-treated recipients Transplantation Proceedings 23(1 Part 1): 373-375
Hauters, P.; de Hemptinne, B.; Carlier, M.; Malaise, J.; Ottobrelli, A.; Delaby, J.; Balducci, G.; Kestens, P.J.; Otte, J.B. 1991: Long-term analysis of glomerular filtration rate and hypertension in adult liver transplant recipients treated with cyclosporine a Transplantation Proceedings 23(1 Part 2): 1458-1459
Wang, M.; Qu, X.; Stepkowski, S.M.; Chou, T.C.; Kahan, B.D. 1996: Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus Transplantation 61(3): 458-464
Diliz, H.S.; Olivera, M.A.; Kershenobich, D.; Mercado, M.A.; Orozco, H. 1996: Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients Transplantation Proceedings 28(6): 3348-3350
Yagisawa, T. 1988: Clinical and pathological studies of cyclosporin-treated kidney transplant recipients. First report: Study of recipients with long-term graft function Nihon Jinzo Gakkai Shi 30(7): 865-873
Salomon, D.R. 1991: An alternative view minimizing the significance of cyclosporine nephrotoxicity and in favor of enhanced immunosuppression for long-term kidney transplant recipients Transplantation Proceedings 23(4): 2115-2118
Tanabe, K.; Takahashi, K.; Sonda, K.; Tokumoto, T.; Koga, S.; Nakazawa, H.; Goya, N.; Yagisawa, T.; Fuchinoue, S.; Kawai, T.; Toma, H.; Ota, K. 1996: Long-term results of OKT3-treated renal transplant recipients Transplantation Proceedings 28(3): 1350-1351
Remberger, M.; Ringden, O.; Aschan, J.; Ljungman, P.; Lönnqvist, B.; Markling, L. 1994: Long-term follow-up of a randomized trial comparing T-cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients Transplantation Proceedings 26(3): 1829-1830
Hernández-Infante, E.; García-Martínez, C.; Beltrán-de-la-Luz, S.; Reyes-Acevedo, R.; Romo-Franco, L.; Delgadillo-Castañeda, R.; Orozco-Loza, I.; Chew-Wong, A. 2010: Prevalence of posttransplant hypertension in pediatric kidney transplant recipients: effect on long term allograft survival Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 62(5): 398-405
Dotti, G.; Gaspari, F.; Caruso, R.; Perico, N.; Remuzzi, G.; Barbui, T.; Rambaldi, A. 2001: Pharmacokinetic study of the new cyclosporine-A formulation (Neoral) in adult allogeneic bone marrow transplant recipients Haematologica 86(3): 311-315
Oka, K.; Shimodaira, H.; Hirano, T.; Sakurai, E.; Tamaki, T.; Kozaki, M. 1993: Comparison of adrenal functions in kidney transplant recipients with different long-term immunosuppressive treatments--prednisolone and azathioprine versus prednisolone and cyclosporine Transplantation 56(3): 603-609
Goulet, O.J.; Revillon, Y.; Gubler, M.C.; Kassis, B.; Jan, D.; Colomb, V.; De Potter, S.; Francois, B.; Sarnacki, S.; Ricour, C. 1994: Renal function and histomorphology after long-term intravenous administration of cyclosporine for small bowel transplantation in pediatric patients Transplantation Proceedings 26(3): 1428
Toledo-Pereyra, L.H.; Raij, L.; Simmons, R.L.; Najarian, J.S. 1974: Role of exdotoxin and bacteria in long-term survival of preserved small-bowel allografts Surgery 76(3): 474-481
Bursztyn, M.; Zelig, O.; Or, R.; Nagler, A. 1997: Isradipine for the prevention of cyclosporine-induced hypertension in allogeneic bone marrow transplant recipients: a randomized, double-blind study Transplantation 63(7): 1034-1036
Carmellini, M.; Romagnoli, J.; Pietrabissa, A.; Di Stefano, R.; Oleggini, M.; Rindi, P.; Rizzo, G.; Mosca, F. 1994: Evaluation of infections in renal transplant recipients treated with cyclosporine Transplantation Proceedings 26(5): 2658-2659
Mihatsch, M.J.; Thiel, G.; Basler, V.; Ryffel, B.; Landmann, J.; von Overbeck, J.; Zollinger, H.U. 1985: Morphological patterns in cyclosporine-treated renal transplant recipients Transplantation Proceedings 17(4 Suppl 1: 101-116
Costanzo-Nordin, M.R.; O'Sullivan, E.J.; Hubbell, E.A.; Zucker, M.J.; Pifarre, R.; McManus, B.M.; Winters, G.L.; Scanlon, P.J.; Robinson, J.A. 1989: Long-term follow-up of heart transplant recipients treated with murine antihuman mature T cell monoclonal antibody (OKT3): the Loyola experience Journal of Heart Transplantation 8(4): 288-295
Schmid, T.; Oberhuber, G.; Thaler, W.; Kaltenbacher, A.; Herbst, P.; Margreiter, R.; Konwalinka, G. 1994: 2-Chlorodeoxyadenosine in combination with cyclosporine prevents rejection after allogeneic small bowel transplantation Transplantation Proceedings 26(3): 1614
Kerman, R.H.; Van Buren, C.T.; Lewis, R.M.; Kahan, B.D. 1988: Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients Transplantation Proceedings 20(3 Suppl 3: 264-269